首页> 美国卫生研究院文献>Molecules >Design Synthesis and Structure-Activity Relationships of Novel Chalcone-123-triazole-azole Derivates as Antiproliferative Agents
【2h】

Design Synthesis and Structure-Activity Relationships of Novel Chalcone-123-triazole-azole Derivates as Antiproliferative Agents

机译:新型查尔酮-123-三唑-唑衍生物作为抗增殖剂的设计合成及构效关系

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A series of novel chalcone-1,2,3-triazole-azole hybrids were designed, synthesized and evaluated for their antiproliferative activity against three selected cancer cell lines (SK-N-SH, EC-109 and MGC-803). Most of the synthesized compounds exhibited moderate to good activity against all the cancer cell lines selected. Particularly, compound >I-21 showed the most excellent antiproliferative activity with an IC50 value of 1.52 μM against SK-N-SH cancer cells. Further mechanism studies revealed that compound >I-21 induced morphological changes of SK-N-SH cancer cells possibly by inducing apoptosis. Novel chalcone-1,2,3-triazole-azole derivatives in this work might be a series of promising lead compounds to develop anticancer agents for treating neuroblastoma.
机译:设计,合成和评价了一系列新颖的查尔酮-1,2,3-三唑-唑杂化物,针对三种选定的癌细胞系(SK-N-SH,EC-109和MGC-803)具有抗增殖活性。大多数合成的化合物对所选的所有癌细胞系均表现出中等至良好的活性。特别地,化合物> I-21 对SK-N-SH癌细胞显示出最优异的抗增殖活性,IC50值为1.52μM。进一步的机理研究表明,化合物> I-21 可能通过诱导细胞凋亡来诱导SK-N-SH癌细胞的形态变化。这项工作中的新型查尔酮-1,2,3-三唑-唑衍生物可能是一系列有前途的先导化合物,以开发用于治疗神经母细胞瘤的抗癌药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号